COVID-19 vaccination intention among patients with psoriasis compared with immunosuppressed patients with other skin diseases and factors influencing their decision
- PMID: 33609286
- PMCID: PMC8014832
- DOI: 10.1111/bjd.19882
COVID-19 vaccination intention among patients with psoriasis compared with immunosuppressed patients with other skin diseases and factors influencing their decision
References
-
- Yiu ZZN, Parisi R, Lunt M et al. Risk of hospitalization and death due to infection in people with psoriasis: a population‐based cohort study using the Clinical Practice Research Datalink. Br J Dermatol 2021; 184:78–86. - PubMed
-
- Smith CH, Yiu ZZN, Bale T et al. British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update. Br J Dermatol 2020; 183:628–37. - PubMed
-
- Nast A, Spuls PI, van der Kraaij G et al. European S3‐Guideline on the systemic treatment of psoriasis vulgaris – update apremilast and secukinumab – EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol 2017; 31:1951–63. - PubMed
-
- Wine‐Lee L, Keller SC, Wilck MB et al. From the Medical Board of the National Psoriasis Foundation: vaccination in adult patients on systemic therapy for psoriasis. J Am Acad Dermatol 2013; 69:1003–13. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
